ACB peer analysis
Aurora Cannabis (ACB) against its competitors: price, today's move, 1-year return and market value side by side.
ACB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.78 | -0.53% | 50.00% | $588.94M |
| BIOA BioAge Labs | $5.79 | -0.09% | -23.45% | – |
| CGC Canopy Growth | $0.71 | 4.72% | -42.51% | $288.00M |
| EDIT Editas Medicine | $2.62 | 1.95% | -14.94% | $394.70M |
| HITI High Tide | $2.59 | 0.39% | -16.72% | – |
| IRWD Ironwood | $3.46 | -1.14% | 80.21% | $571.73M |
| LFCR Lifecore Biomedical | $6.42 | 0.47% | -10.71% | – |
| LFMD LifeMD | $2.27 | -1.73% | -61.59% | – |
| OGI Organigram Global | $0.97 | 3.43% | -40.43% | $139.12M |
| TKNO Alpha Teknova | $7.23 | 3.14% | 37.71% | – |
| ACB Aurora Cannabis | $5.04 | 19.43% | 1.82% | $267.17M |
- ACB's peers: ACRS (Aclaris Therapeutics), BIOA (BioAge Labs), CGC (Canopy Growth), EDIT (Editas Medicine), HITI (High Tide), IRWD (Ironwood), LFCR (Lifecore Biomedical), LFMD (LifeMD).
Updated 2026-11-03 17:27 UTC